These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis. Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731 [TBL] [Abstract][Full Text] [Related]
5. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients. Rombouts AJM; Hugen N; Verhoeven RHA; Elferink MAG; Poortmans PMP; Nagtegaal ID; de Wilt JHW Eur J Surg Oncol; 2018 Jul; 44(7):1018-1024. PubMed ID: 29678303 [TBL] [Abstract][Full Text] [Related]
6. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. You YN; Dozois EJ; Boardman LA; Aakre J; Huebner M; Larson DW Ann Surg Oncol; 2011 Sep; 18(9):2469-76. PubMed ID: 21448750 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Hyngstrom JR; Hu CY; Xing Y; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA; Cormier JN; Chang GJ Ann Surg Oncol; 2012 Sep; 19(9):2814-21. PubMed ID: 22476818 [TBL] [Abstract][Full Text] [Related]
8. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis. Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162 [TBL] [Abstract][Full Text] [Related]
9. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy rather than neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer with high tumor burden. Koca D; Oztop J; Yilmaz U Hepatogastroenterology; 2012 Oct; 59(119):2151-4. PubMed ID: 22440247 [TBL] [Abstract][Full Text] [Related]
11. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes. Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151 [TBL] [Abstract][Full Text] [Related]
13. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters. Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561 [TBL] [Abstract][Full Text] [Related]
14. Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database. Poles GC; Clark DE; Mayo SW; Beierle EA; Goldfarb M; Gow KW; Goldin A; Doski JJ; Nuchtern JG; Vasudevan SA; Langer M J Pediatr Surg; 2016 Jul; 51(7):1061-6. PubMed ID: 26703433 [TBL] [Abstract][Full Text] [Related]
15. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237 [TBL] [Abstract][Full Text] [Related]
16. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis. Brunner W; Widmann B; Marti L; Tarantino I; Schmied BM; Warschkow R Surg Endosc; 2016 Oct; 30(10):4405-15. PubMed ID: 26895892 [TBL] [Abstract][Full Text] [Related]
17. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780 [TBL] [Abstract][Full Text] [Related]
18. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy. Xu Z; Berho ME; Becerra AZ; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JRT; Fleming FJ J Clin Pathol; 2017 Jul; 70(7):584-592. PubMed ID: 27932667 [TBL] [Abstract][Full Text] [Related]
19. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841 [TBL] [Abstract][Full Text] [Related]
20. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Secco GB; Fardelli R; Campora E; Lapertosa G; Gentile R; Zoli S; Prior C Oncology; 1994; 51(1):30-4. PubMed ID: 8265100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]